drugset / Trial / NCT06366750
A Study of Barzolvolimab in Patients With Prurigo Nodularis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
Timeline
- Start
- 2024-04-12
- Primary completion
- 2026-06
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | barzolvolimab | Monoclonal antibody | 150 mg | Subcutaneous |
| Subject | barzolvolimab | Monoclonal antibody | 300 mg | Subcutaneous |